![](/img/cover-not-exists.png)
Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation
Kancha, R. K., von Bubnoff, N., Miething, C., Peschel, C., Gotze, K. S., Duyster, J.Volume:
93
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.13207
Date:
September, 2008
File:
PDF, 152 KB
english, 2008